High Frequency of Unrecognized Indolent Hematological Disorders Among HLA-matched Siblings of Patients With Lymphoproliferative Malignancies Eligible for Allo-SCT

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2008.183
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Outbreak of Ralstonia Pickettii Pseudobacteremia Among Patients With Hematological Malignancies

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
2006English

Treatment of Hematological Malignancies With Nonmyeloablative, HLA-haploidentical Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide

Best Practice and Research in Clinical Haematology
OncologyClinical Biochemistry
2011English

Chronic Disseminated Candidiasis Manifesting as Hepatosplenic Abscesses Among Patients With Hematological Malignancies

BMC Infectious Diseases
Infectious Diseases
2019English

Risk of Pneumococcal Septicaemia in Patients With Chronic Lymphoproliferative Malignancies

BMJ
1995English

Genetic and Phenotypic Characterization of Indolent T-Cell Lymphoproliferative Disorders of the Gastrointestinal Tract

Haematologica
Hematology
2019English

Escalating-Dose HLA-mismatched DLI Is Safe for the Treatment of Leukaemia Relapse Following Alemtuzumab-Based Myeloablative Allo-SCT

Bone Marrow Transplantation
TransplantationHematology
2013English

Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab From HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients With Hematologic Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Improved Outcome of Critically Ill Patients With Hematological Malignancies: What’s Next?

Intensive Care Medicine
Critical CareIntensive Care Medicine
2014English

Treatment of Hematological Malignancies With Glycyrrhizic Acid

Anticancer Research
MedicineCancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy